https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Exosome-based therapy is an emerging novel approach for myocardial infarction (MI) treatment. Exosomes are identified as extracellular vesicles that are produced within multi vesicular bodies in the cells cytosols and then are secreted from the cells. Exosomes are 30-100 nm in diameter that are released from viable cells and are different from other secreted vesicles such as apoptotic bodies and microvesicles in their origin and contents such as RNAs, proteins and nucleic acid. The recent advances in exosomes research
Like
Comment
Share
